Sign in
4

Changes in Ownership

Protagonist Therapeutics, Inc Filed Acc 0001209191-17-061002

Chief Scientific Officer sold 7,000 shares at $16.97 ($118,761)

  • Chief Scientific Officer acquired 7,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Liu David Y · Chief Scientific Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2017-11-13 Exercise or conversion : show line 1 in the form +3,500 $4.21 $14,735 7,322 D
2017-11-13 Sale : show line 2 in the form −3,500 $16.97 $59,381 3,822 D
2017-11-13 Exercise or conversion : show line 3 in the form +3,500 $1.89 $6,615 7,322 D
2017-11-13 Sale : show line 4 in the form −3,500 $16.97 $59,381 3,822 D
Open-market sales · 7,000 sh · avg $16.97 · $118,761

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2017-11-13 Exercise or conversion : show line 5 in the form Employee Stock Option (right to buy) −3,500 38,831 D
2017-11-13 Exercise or conversion : show line 6 in the form Employee Stock Option (right to buy) −3,500 13,225 D
Loading xslF345X03/doc4.xml…